March 2, 2024 Comments Off on New patent for Merck Sharp drug PREVYMIS Posted in: Patent Added Annual Drug Patent Expirations for PREVYMIS Prevymis is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are three…
The post New patent for Merck Sharp drug PREVYMIS appeared first on DrugPatent…
March 2, 2024 Comments Off on New patent for Astrazeneca drug LYNPARZA Posted in: Patent Added Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eleven patents protecting…
The post New patent for Astrazeneca drug LYNPARZA appeared first…
